OncoHelix is a precision diagnostics company founded and headquartered in Calgary, Alberta in 2019. OncoHelix provides specialty molecular and immune testing services, utilizing cutting edge technologies in the areas of tumour genetic profiling, transplant immunology, reproductive health, and wellness testing. OncoHelix is a proud testing partner of 5 public healthcare programs as well as pharma-sponsored testing programs with companies including AstraZeneca, Roche, Pfizer, Incyte and Esperas. OncoHelix performs R&D at our Calgary headquarters in addition to revenue generating operations, validating diagnostic tests for use in export markets as well as within Canada. OncoHelix is promoting it\\\'s full menu of testing services, including molecular profiling for oncology, transplant immunology, reproductive health, and wellness. OncoHelix is looking to expand our customer base to new clinics, hospitals, and government health programs across Asia, through our CAP-accredited lab in the UAE.